In mid-September, we suggested that investors take a closer look at Pfizer, the big ($211 billion market cap) pharmaceutical company. This article is for paid members - please login or subscribe for access. Username Password Remember Me Forgot Password Share: Mark W. Guthner, CFA Previous Post AMAT: Applied MaterialsNext PostThe bullish case for gold, silver and bitcoin in the long run You Might Also Like Netflix Update January 17, 2019 Amazon Inc. (AMZN) Return to the Jungle November 20, 2019 Here we go again January 2, 2019
You Might Also Like Netflix Update January 17, 2019 Amazon Inc. (AMZN) Return to the Jungle November 20, 2019 Here we go again January 2, 2019
